Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HINOYOTCMKTS:HNLGYOTCMKTS:HTCMYOTCMKTS:SWTUY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHINOYHino Motors$25.00$30.29$22.57▼$34.18N/A0.03430 shs20 shsHNLGYHang Lung Group$8.28+1.8%$7.20$5.28▼$8.28$7.45B0.176 shs440 shsHTCMYHitachi Constr$59.31$58.91$40.85▼$60.02$6.31B0.3927 shsN/ASWTUYSWEDISH ORPHAN/S$24.38-1.2%$24.38$18.50▼$31.96$6.64B1.811,665 shs200 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHINOYHino Motors0.00%-2.80%-19.35%-22.70%-11.97%HNLGYHang Lung Group0.00%+1.84%+16.61%+20.08%+50.81%HTCMYHitachi Constr0.00%0.00%0.00%+8.86%+16.10%SWTUYSWEDISH ORPHAN/S0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHINOYHino MotorsN/AN/AN/AN/AN/AN/AN/AN/AHNLGYHang Lung GroupN/AN/AN/AN/AN/AN/AN/AN/AHTCMYHitachi ConstrN/AN/AN/AN/AN/AN/AN/AN/ASWTUYSWEDISH ORPHAN/SN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHINOYHino Motors 0.00N/AN/AN/AHNLGYHang Lung Group 0.00N/AN/AN/AHTCMYHitachi Constr 0.00N/AN/AN/ASWTUYSWEDISH ORPHAN/S 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHINOYHino Motors$11.15BN/AN/AN/AN/AN/AHNLGYHang Lung Group$1.51B4.94$0.43 per share19.32$20.09 per share0.41HTCMYHitachi Constr$9.01B0.70$9.52 per share6.23$53.24 per share1.11SWTUYSWEDISH ORPHAN/S$763.19M8.71$0.70 per share34.66$2.88 per share8.47Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHINOYHino Motors-$1.44B-$25.51N/A∞N/A-13.14%-90.57%-18.24%7/23/2025 (Estimated)HNLGYHang Lung Group$276.02MN/A0.00∞N/AN/AN/AN/A7/28/2025 (Estimated)HTCMYHitachi Constr$537.42M$5.4510.8811.04N/AN/AN/AN/A7/25/2025 (Estimated)SWTUYSWEDISH ORPHAN/S$134.73M$0.5048.7616.931.3025.75%29.63%18.74%N/ALatest HINOY, SWTUY, HNLGY, and HTCMY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/24/2025Q4 2025HINOYHino MotorsN/A$1.00N/A$5.44N/A$2.74 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHINOYHino MotorsN/AN/AN/AN/AN/AHNLGYHang Lung Group$0.789.42%N/AN/AN/AHTCMYHitachi Constr$2.293.86%N/A42.02%N/ASWTUYSWEDISH ORPHAN/SN/AN/AN/AN/AN/ALatest HINOY, SWTUY, HNLGY, and HTCMY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/2/2025HNLGYHang Lung Group$0.39917.39%5/8/20255/9/20256/26/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHINOYHino Motors0.150.820.54HNLGYHang Lung Group0.340.71N/AHTCMYHitachi Constr0.251.630.77SWTUYSWEDISH ORPHAN/SN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHINOYHino MotorsN/AHNLGYHang Lung GroupN/AHTCMYHitachi ConstrN/ASWTUYSWEDISH ORPHAN/SN/AInsider OwnershipCompanyInsider OwnershipHINOYHino MotorsN/AHNLGYHang Lung GroupN/AHTCMYHitachi ConstrN/ASWTUYSWEDISH ORPHAN/SN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHINOYHino Motors33,314N/AN/ANot OptionableHNLGYHang Lung Group4,200899.85 millionN/ANot OptionableHTCMYHitachi Constr26,230106.35 millionN/ANot OptionableSWTUYSWEDISH ORPHAN/S902272.51 millionN/ANot OptionableHINOY, SWTUY, HNLGY, and HTCMY HeadlinesRecent News About These CompaniesSwedish Orphan Biovitrum AB: Sobi and Apellis: Aspaveli/Empaveli Demonstrates Sustained One-Year Efficacy in Phase 3 Study for Rare Kidney DiseasesJune 6, 2025 | finanznachrichten.deSwedish health minister pressed to fund orphan drug accessMay 30, 2025 | euractiv.comSwedish Orphan Biovitrum AB: Sobi to share new clinical data and research at EULAR 2025May 28, 2025 | finanznachrichten.deBerenberg cuts SOBI stock target to SEK360, maintains buyApril 18, 2025 | uk.investing.comSobi announces a new research collaboration on the development of Gamifant in sepsis, which is to be presented at the ISICEM congressMarch 21, 2025 | pharmabiz.comRBC Capital Remains a Buy on Swedish Orphan Biovitrum AB (0MTD)January 14, 2025 | markets.businessinsider.comSobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune ThrombocytopeniaDecember 12, 2024 | markets.businessinsider.comSobi North America Says SNDA Accepted For Avatrombopag In Paediatric Immune ThrombocytopeniaDecember 12, 2024 | markets.businessinsider.comLarger Study Supports Safety of Tetracyclines During Early PregnancyNovember 14, 2024 | medpagetoday.comSobi to present new data across its immunology portfolio at the ACR Convergence 2024November 7, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB: Sobi Q3 2024 report: Strong growth and significant pipeline momentumOctober 24, 2024 | finanznachrichten.deSobi Q3 2024 report: Strong growth and significant pipeline momentumOctober 24, 2024 | finance.yahoo.comMerck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In InfantsOctober 18, 2024 | benzinga.comMerck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17)October 18, 2024 | msn.comHigh Growth Tech Stocks In Sweden With Promising PotentialOctober 17, 2024 | finance.yahoo.comMerck's RSV antibody for infants shows over 60% efficacy in mid-late-stage studyOctober 17, 2024 | reuters.comThe Swedish Royal Family and Its Members, ExplainedOctober 9, 2024 | vogue.comExploring Sweden's High Growth Tech GiantsOctober 2, 2024 | uk.finance.yahoo.comNew Swedish law enables government funding for babysitting grandparentsSeptember 27, 2024 | yahoo.comEurope's CHMP turns down Apellis' pegcetacoplan appeal, endorses new drugs from Pfizer, ImmunoGen and HenliusSeptember 20, 2024 | fiercepharma.comMedia Sentiment Over TimeHINOY, SWTUY, HNLGY, and HTCMY Company DescriptionsHino Motors OTCMKTS:HINOY$25.00 0.00 (0.00%) As of 06/20/2025Hino Motors, Ltd. manufactures and sells large commercial vehicles under the Hino brand worldwide. It offers trucks and buses; and light commercial vehicles and passenger vehicles, as well as various engines, service parts, etc. The company was founded in 1910 and is headquartered in Hino, Japan. Hino Motors, Ltd. operates as a subsidiary of Toyota Motor Corporation.Hang Lung Group OTCMKTS:HNLGY$8.28 +0.15 (+1.84%) As of 06/20/2025 09:36 AM EasternHang Lung Group Limited, an investment holding company, operates as a property developer in Hong Kong and the Mainland of China. The company operates through Property Leasing and Property Sales segments. It develops properties for sale and lease, such as large-scale commercial, office, and residential developments. The company also invests in and develops various properties, including shopping malls, office premises, residential and industrial premises, and car parking bays. In addition, its investment properties portfolio includes Grand Gateway 66, a commercial, office, and residential complex, as well as Plaza 66, a commercial and office complex in Shanghai; Palace 66 and Forum 66 in Shenyang; Parc 66 in Jinan; Center 66 in Wuxi; Riverside 66 in Tianjin; Olympia 66 in Dalian; Spring City 66 in Kunming; and Heartland 66 in Wuhan. Further, the company offers car park and property management, financial, management, project management, and property agency services, as well as operates and manages apartment. Hang Lung Group Limited was incorporated in 1960 and is headquartered in Central, Hong Kong.Hitachi Constr OTCMKTS:HTCMY$59.31 0.00 (0.00%) As of 06/20/2025Hitachi Construction Machinery Co., Ltd., together with its subsidiaries, manufactures and sells construction machineries worldwide. The company operates through two segments, Construction Machinery Business and Solution Business. It offers excavators and wheel loaders, hydraulic excavators, compaction equipment, and rigid dump trucks. The company also provides ICT construction solutions; ConSite that monitors machines' operational status and alarms by sending monthly operational reports, as well as notifies emergency alarms; Fleet management system, which offers real-time monitoring of dump truck for optimizing vehicle operations; and autonomous haulage system for autonomous operation of mining dump trucks. In addition, it provides parts and services; used equipment under the PREMIUM USED brand; machinery rental services under the PREMIUM RENTAL and REC brand names; and parts remanufacturing services. The company was incorporated in 1951 and is headquartered in Taito, Japan. Hitachi Construction Machinery Co., Ltd. is a subsidiary of Hitachi, Ltd.SWEDISH ORPHAN/S OTCMKTS:SWTUY$24.38 -0.29 (-1.18%) As of 04/9/2019Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
